Literature DB >> 18330621

Laparoscopic adrenalectomy for metachronous metastasis from renal cell carcinoma.

Stéphane Bonnet1, Sébastien Gaujoux, Mahaut Leconte, Jean-Marc Thillois, Frédérique Tissier, Bertrand Dousset.   

Abstract

BACKGROUND: Metachronous adrenal metastases (AM) from renal cell carcinoma (RCC) are rare. We report our experience of surgical resection in this setting, with particular respect to laparoscopic approach and long-term outcome.
METHODS: A retrospective review of 11 patients who underwent adrenalectomy for metachronous AM from RCC was conducted between 2002 and 2005 in a tertiary referral center.
RESULTS: CT scan findings were those of an adrenal mass ranging from 2 to 13 cm in diameter with a basal density of 12 to 28 Hounsfield Units and strong heterogeneous enhancement following contrast injection. The surgical procedure consisted of controlateral (n = 5), ipsilateral (n = 2), and bilateral (n = 1) laparoscopic adrenalectomy, whereas three patients underwent controlateral open adrenalectomy for adrenal mass >10 cm. Nine patients were recurrence-free with a median follow-up of 34 months. In the remaining two patients, lung metastases were discovered at postoperative months 28 and 11, respectively. The former patient is alive and free of disease recurrence 32 months after lung metastasis resection, whereas the latter is currently being treated with sunitinib.
CONCLUSIONS: This study confirms that prolonged overall and disease free-survival can be achieved in selected patient after laparosocpic adrenalectomy for AM from RCC.

Entities:  

Mesh:

Year:  2008        PMID: 18330621     DOI: 10.1007/s00268-008-9539-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  26 in total

Review 1.  Renal-cell carcinoma.

Authors:  Herbert T Cohen; Francis J McGovern
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

Review 2.  Metachronous renal cell carcinoma metastasis to the contralateral adrenal gland.

Authors:  O J Kessler; E Mukamel; R Weinstein; E Gayer; M Konichezky; C Servadio
Journal:  Urology       Date:  1998-04       Impact factor: 2.649

3.  Liver resection for metastases from renal cell carcinoma.

Authors:  Armin Thelen; S Jonas; C Benckert; E Lopez-Hänninen; B Rudolph; U Neumann; P Neuhaus
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

4.  Results of laparoscopic adrenalectomy for large and potentially malignant tumors.

Authors:  Jean-François Henry; Frederic Sebag; Maurizio Iacobone; Eric Mirallie
Journal:  World J Surg       Date:  2002-06-06       Impact factor: 3.352

Review 5.  Epidemiologic aspects of renal cell cancer.

Authors:  J K McLaughlin; L Lipworth
Journal:  Semin Oncol       Date:  2000-04       Impact factor: 4.929

Review 6.  Renal cell carcinoma: current status and future prospects.

Authors:  Beverly J Drucker
Journal:  Cancer Treat Rev       Date:  2005-10-17       Impact factor: 12.111

7.  Contralateral adrenal metastasis of renal cell carcinoma: treatment, outcome and a review.

Authors:  W K Lau; H Zincke; C M Lohse; J C Cheville; A L Weaver; M L Blute
Journal:  BJU Int       Date:  2003-06       Impact factor: 5.588

8.  Isolated adrenal metastasis: the role of laparoscopic surgery.

Authors:  F Sebag; F Calzolari; J Harding; M Sierra; F F Palazzo; J F Henry
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

9.  Laparoscopic adrenalectomy for suspected metastasis of adrenal glands: our experience.

Authors:  Octavio A Castillo; Gonzalo Vitagliano; Marcelo Kerkebe; Paolo Parma; Ivan Pinto; Manuel Diaz
Journal:  Urology       Date:  2007-04       Impact factor: 2.649

10.  Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST).

Authors:  B Nilsson; K Sjölund; L-G Kindblom; J M Meis-Kindblom; P Bümming; O Nilsson; J Andersson; H Ahlman
Journal:  Br J Cancer       Date:  2007-05-29       Impact factor: 7.640

View more
  7 in total

Review 1.  Has laparoscopy impacted the indications for adrenalectomy?

Authors:  David W Hall; Jay D Raman
Journal:  Curr Urol Rep       Date:  2010-03       Impact factor: 3.092

Review 2.  Metachronous contralateral testicular and bilateral adrenal metastasis of chromophobe renal cell carcinoma: a case report and review of the literature.

Authors:  Hai-Yang Wu; Li-Wei Xu; You-Yun Zhang; Yan-Lan Yu; Xin-de Li; Gong-Hui Li
Journal:  J Zhejiang Univ Sci B       Date:  2010-05       Impact factor: 3.066

3.  Adrenalectomy improves outcomes of selected patients with metastatic carcinoma.

Authors:  Bianca J Vazquez; Melanie L Richards; Christine M Lohse; Geoffrey B Thompson; David R Farley; Clive S Grant; Marianne Huebner; Jose Moreno
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

4.  The role of laparoscopic resection of metastases to adrenal glands.

Authors:  Marco Puccini; Erica Panicucci; Vincenzo Candalise; Cristina Ceccarelli; Carlo Maria Neri; Piero Buccianti; Paolo Miccoli
Journal:  Gland Surg       Date:  2017-08

Review 5.  Surgical management of metastases to the adrenal gland: open, laparoscopic, and ablative approaches.

Authors:  Jayant Uberoi; Ravi Munver
Journal:  Curr Urol Rep       Date:  2009-01       Impact factor: 3.092

6.  Metachronous metastasis to the spermatic cord from renal cell carcinoma presenting as a high scrotal mass: a case report.

Authors:  Afshin Mohammadi; Khadijeh Makhdoomi; Mohammad Ghasemi-rad
Journal:  Cancer Imaging       Date:  2011-11-26       Impact factor: 3.909

7.  Prognostic factors for recurrence-free and overall survival after adrenalectomy for metastatic carcinoma: a retrospective cohort pilot study.

Authors:  Eu Chang Hwang; Insang Hwang; Seung Il Jung; Taek Won Kang; Dong Deuk Kwon; Suk Hee Heo; Jun Eul Hwang; Sung Gu Kang; Seok Ho Kang; Jeong Gu Lee; Je Jong Kim; Jun Cheon
Journal:  BMC Urol       Date:  2014-05-23       Impact factor: 2.264

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.